Lockdown life: did staying home help young diabetics manage blood sugar?

NCT ID NCT04669912

Completed Knowledge-focused Sponsor: Centre Hospitalier Sud Francilien Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how the COVID-19 lockdown changed blood sugar control and self-care in 77 young people aged 13 to 25 with type 1 diabetes. Researchers used data from a glucose monitoring platform to compare blood sugar levels before, during, and after the two-month lockdown in France. The goal was to see if the lockdown led to better glucose control and more consistent use of glucose sensors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show that certain lifestyle changes during lockdown improved diabetes management, pointing to new ways to support young people with type 1 diabetes.
What could go wrong: This is a small, completed observational study, not a treatment trial. Results may not apply to all young people with diabetes, and any improvements seen might not last outside lockdown conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, 91100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.